ProCE Banner Activity

New Adjuvant Treatment Strategies for Early-Stage HER2-Positive Breast Cancer: Clinical and Shared Decision Making Implications for the Oncology Nurse

Slideset Download
These downloadable slides, from our live meeting series on adjuvant therapy for HER2+ EBC, review the current clinical rational and most recent data on dual HER2-targeted adjuvant therapy with trastuzumab and pertuzumab as well as the use of extended therapy with neratinib for patients at high risk of disease recurrence.

Released: April 19, 2018

Expiration: April 18, 2019

Share

Provided by

Provided by Postgraduate Institute for Medicine
ProCE Banner

Supporters

This activity is supported by educational grants from

Genentech TEXT Only

Puma Biotechnology, Inc.